<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02357381</url>
  </required_header>
  <id_info>
    <org_study_id>SpringTMSUSPMOS 2014-01</org_study_id>
    <nct_id>NCT02357381</nct_id>
  </id_info>
  <brief_title>eNeura SpringTMS Post-Market Observational US Study of Migraine</brief_title>
  <acronym>ESPOUSE</acronym>
  <official_title>eNeura SpringTMS Post-Market Observational U.S. Study of Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>eNeura, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Daniel &amp; Daniel Consulting LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>eNeura, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center, prospective, non-randomized, single arm, open label, post-market,
      observational study to evaluate the use of the eneura, springtms system in reduction of
      migraine headache symptoms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, non-randomized, single arm, multi-center observational study designed to
      evaluate the use of the SpringTMS system in reducing the frequency of headache days.

      Note: This is a NON-SIGNIFICANT RISK (NSR) study of a NON-SIGNIFICANT RISK (NSR) Device. It
      is a post market study of a NSR device cleared by FDA through the 510(k) pre-market
      notification process. The cleared indications for use are provided above. This NSR study is
      designed to collect information on additional applications of the SpringTMS device. These
      additional applications include:

        1. Use of the device to evaluate the potential for regular use of sTMS to reduce the
           frequency, severity, and/or duration of migraine.

        2. Delivery of additional treatments (pulses) to evaluate the acute treatment efficacy of
           breakthrough migraine attacks with and without aura.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Headache Days</measure>
    <time_frame>3 months</time_frame>
    <description>Reduction in mean headache days</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Headache</condition>
  <arm_group>
    <arm_group_label>TMS Treatment</arm_group_label>
    <description>TMS( transcranial magnetic stimulation) -treatment for headache</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>eNeura SpringTMS</intervention_name>
    <description>Single pulse magnetic stimulation for prevention and/or treatment of migraine headache with or without aura.</description>
    <arm_group_label>TMS Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        4-25 headache days per month (confirmed by 1-month baseline diary, minimum of 5 complete
        headache-free days/month)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients 18 to 65 years of age;

          2. Patients able to understand and communicate in English;

          3. Migraine with or without aura;

          4. 4-25 headache days per month (confirmed by 1-month baseline diary, minimum of 5
             complete headache-free days/month);

          5. Understand and willing to provide diary and survey data.

        Exclusion Criteria:

          -  Subjects will be excluded from participating in this trial if they meet any of the
             following criteria

               1. Severe co-existing disease having a life expectancy of less than 1 year;

               2. Currently involved in any other investigational clinical trials that have not
                  completed their primary endpoint or that may interfere with the SpringTMS study
                  results;

               3. Mental impairment or other conditions which may not allow the subject to
                  understand the nature, significance and scope of the study and to cooperate with
                  follow-up requirements;

               4. Known drug and/or alcohol addiction or use of illicit substances;

               5. Patients with epilepsy or history of seizure;

               6. Severe active major depression or major psychiatric illness;

               7. Concurrent use of other neurostimulation devices (Cefaly®, TENS, implantable
                  devices);

               8. Use of Botox® within past 4 months;

               9. Extracranial nerve block (e.g. occipital, supraorbital) within past 3 months;

              10. Use of Cefaly for prevention within past month;

              11. Patients with metal containing implants as follows:

        The SpringTMS may not be used in patients who have metals, conductive materials, or
        metal-containing implants in their head, neck or upper body. Patients with implants that
        are affected by a magnetic field should not use the SpringTMS. Examples of such implants
        include:

          -  Aneurysm clips or coils • Radioactive seeds

          -  Cochlear implants • Magnetically programmable shunt valves

          -  Cerebral spinal fluid shunts • Stents

          -  Bullets or pellets lodged in the head or upper body • Metal plates, screws, staples or
             sutures in skull, neck, shoulders, arms or hands

          -  Filters • Metallic artificial heart valves

          -  Electrodes • Facial tattoos with metallic ink Dental implants, fillings, or other
             dental appliances are okay and are not affected by the device.

        Note: although not explicitly excluded, safety and effectiveness have not been established
        in pregnant women. Please defer to the judgment of the investigator when considering the
        eligibility of this population.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David W Dodick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic , Phoenix,AZ</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cynthia Harris, BS</last_name>
    <phone>775-392-2970</phone>
    <email>cindy@clinregconsult.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Daniel, BS,MS,MBA</last_name>
    <phone>775-392-2970</phone>
    <email>cindy@clinregconsult.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UCLA Headache Research and Treatment Program</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andrew Charles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford Headache Program</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94563</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evalina Salas</last_name>
      <phone>650-723-6469</phone>
      <email>evalinas@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Nada Ahmad Hindiyeh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mid Atlantic Permanente Medical Group-Kaiser</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20852</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aundria Cosby, RN,BSN,CCRP</last_name>
      <phone>301-816-6378</phone>
      <email>Aundria.C.Cosby@kp.org</email>
    </contact>
    <investigator>
      <last_name>Ejaz Shamin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albert Einstein College of Medicine</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eileen Summers</last_name>
      <email>esummers@brany.com</email>
    </contact>
    <contact_backup>
      <last_name>Khosrow Rezagholi</last_name>
      <email>krezagho@montefiore.org</email>
    </contact_backup>
    <investigator>
      <last_name>Matthew Robbins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai St. Luke's and Mount Sinai Roosevelt</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Iris Harris</last_name>
      <email>iharris@CHPNET.ORG</email>
    </contact>
    <investigator>
      <last_name>Lawrence Newman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic Center for Headache and Pain</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Zeleny</last_name>
      <phone>216-636-5549</phone>
      <email>ZELENYM@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Stewart Tepper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jefferson Headache Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Bradley, RN,BSN</last_name>
      <phone>215-955-2546</phone>
      <email>Kathleen.Bradley@jefferson.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rose Tausendfreundt</last_name>
      <phone>215-503-8542</phone>
      <email>Rose.Tausendfreundt@jefferson.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Marmura, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2015</study_first_submitted>
  <study_first_submitted_qc>February 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2015</study_first_posted>
  <last_update_submitted>October 9, 2015</last_update_submitted>
  <last_update_submitted_qc>October 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

